“Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms — A Narrative Review” was published recently in the journal Neurology and Therapy. The authors, which included Bryan Davis, Psy.D., Clinical Health Psychologist with Norton Neuroscience Institute, wrote about the importance of destigmatizing multiple sclerosis (MS) symptoms that may not be visible to providers. Underlying…
Bracing can significantly decrease the progression of idiopathic adolescent scoliosis and can prevent the need for surgery in teenage patients who wear the brace for 16 to 18 hours a day, according to an orthopedic surgeon at Norton Children’s Orthopedics of Louisville, affiliated with the UofL School of Medicine. “Bracing is appropriate if the scoliosis…
John W. McConnell, M.D., recently joined Norton Pulmonary Specialists, but he has been a leading pulmonologist in Louisville for three decades, known for his work with pulmonary hypertension. Dr. McConnell is medical director of the Norton Healthcare Pulmonary Hypertension Program, which regularly participates in clinical trials that give patients access to the latest treatments for…
Enhanced Recovery After Surgery (ERAS) protocols have the potential to hasten recovery from lumbar fusion surgery for degenerative spine conditions, with reduced in-hospital opioid consumption and improved postoperative pain scores, according to a study published recently in Global Spine Journal. ERAS, which includes preoperative counseling, nutritional and medical optimization, standardized pain management and anesthesia, and…
A new cystic fibrosis treatment is now available for children ages 6 to 11. The drug Trikafta was previously prescribed only to children 12 and older. In June, the Food and Drug Administration approved Trikafta (a three-drug combination of elexacaftor, ivacaftor and tezacaftor) after clinical trials with younger patients showed the treatment generally had the…
Victoria A. Statler, M.D., M.S., offers specialized care in a relatively new field: pediatric transplant infectious diseases. Dr. Statler, a pediatric infectious diseases specialist with Norton Children’s Infectious Diseases, affiliated with the UofL School of Medicine, educates children undergoing solid organ and stem cell transplants and their caregivers on ways to avoid potentially dangerous infections….
One of the most common reasons adolescents have heavy menstrual bleeding is they’re having anovulatory periods — they aren’t releasing an egg monthly from an ovary, so when they do bleed it’s because the uterus lining has outgrown the blood supply. “This is the reason why you have cycles that are every 21 to 45…
A bone health program to prevent fractures, and platelet-rich plasma (PRP) injections for overuse injuries, joint arthritis and other tendon and ligament injuries are among the nonsurgical interventions offered by Norton Orthopedic Institute. Platelet rich plasma therapy Patients with orthopedic injuries such as tennis elbow or chronic joint arthritis often improve with platelet-rich plasma (PRP)…
Based on the data so far, the Pfizer, Moderna and Johnson & Johnson vaccines for COVID-19 are considered safe for people with multiple sclerosis (MS) and safe to use while on disease-modifying therapies, according to Geeta A. Ganesh, M.D., a Norton Neuroscience Institute neurologist who specializes in MS care. Coordinating the vaccine with some MS medications…
Joyce Achenjang, M.D. Hospital Medicine Jason L. Crowell, M.D. Neurology Elsa S. Kuhl, M.D. Diagnostic Radiology Laith J. Sweis, M.D. Family Medicine Kaitlyn Tinius, APRN Pulmonology Michael Bailey, PA-C Pulmonology Kelley Morris, APRN Family Medicine
Every day at Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, pharmacists round with the teams. We’re part of the decision-making process for hematology, oncology and stem cell transplant patients. Our goal is to help give these children the best possible outcome and keep them safe. For many patients, this involves following…
A new drug has revolutionized the care of children with moderate to severe hemophilia A, not only dramatically improving their quality of life but potentially eliminating future complications from the disease. Hemophilia A affects 1 in 5,000 male births, making it the most common congenital severe bleeding disorder. Until recently, the mainstay of treatment for…